Considering that miR-125b targets a wide spectrum of genes including PTGS2 and ETS1, and that miRNAs are proposed as tools for cancer therapy, we tested miR-125b alone or in combination with NS-398, a specific chemical inhibitor of PTGS228. Here, ETS1 is linked to cancer.